Internal Medicine, Geriatric Medicine · Los Angeles, CA
NPI
1396775474
Since 2006
Specialty
Internal Medicine, Geriatric Medicine
Code 207RG0300X
Group practices
0
Medicare group memberships
Hospitals
2
Hospital affiliations
6245 de Longpre Ave, Fl 2
Los Angeles, CA, 90028
Phone (323) 499-1350
Medicare paid, 2024
$459K
5,482 services
Medicare patients, 2024
799
Average age 73
Drug cost, 2024
$4.4M
46,460 prescriptions
Company payments, 2025
$882
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marcel S Filart was code 99308 (snf e&m), 1,440 times for 389 patients. In total Marcel S Filart billed 5,482 services in 42 codes, and Medicare paid $459K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Office | 1,440 | 389 | $56.95 | $82K |
| 99309 SNF E&M | Office | 1,021 | 370 | $79.39 | $81K |
| 99349 Home E&M - New and Established | Office | 568 | 84 | $94.78 | $54K |
| 99239 Hospital Discharge Management | Facility | 387 | 268 | $86.63 | $34K |
| 99305 SNF E&M | Office | 360 | 239 | $100.87 | $36K |
| 99233 Hospital E&M - Subsequent | Facility | 332 | 203 | $88.64 | $29K |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 321 | 221 | $220.96 | $71K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 216 | 67 | $45.59 | $9,847 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 133 | 51 | $78.27 | $10K |
| 99223 Hospital E&M - Initial | Facility | 96 | 86 | $129.41 | $12K |
| 99214 Office E&M - Established | Office | 87 | 49 | $97.01 | $8,439 |
| 99310 SNF E&M | Office | 74 | 64 | $116.95 | $8,654 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 73 | 59 | $40.33 | $2,944 |
| 99348 Home E&M - New and Established | Office | 64 | 37 | $58.00 | $3,712 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 58 | 31 | $35.25 | $2,044 |
By year: 2022 $345K for 3,996 services; 2023 $402K for 4,391 services; 2024 $459K for 5,482 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marcel S Filart prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,543 prescriptions and refills. In total Marcel S Filart wrote 46,460 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,543 | 3,083 | 437 | $33K |
| Amlodipine Besylate Generic | 1,917 | 2,483 | 343 | $15K |
| Gabapentin Generic | 1,406 | 1,672 | 251 | $21K |
| Levothyroxine Sodium Generic | 1,307 | 1,459 | 176 | $16K |
| Famotidine Generic | 1,209 | 1,334 | 209 | $14K |
| Pantoprazole Sodium Generic | 1,061 | 1,201 | 199 | $25K |
| Metformin Hcl Generic | 1,024 | 1,341 | 175 | $11K |
| Eliquis Apixaban | 959 | 975 | 107 | $292K |
| Losartan Potassium Generic | 879 | 1,271 | 187 | $8,614 |
| Furosemide Generic | 802 | 913 | 141 | $5,974 |
| Metoprolol Tartrate Generic | 729 | 857 | 134 | $6,418 |
| Tamsulosin Hcl Generic | 722 | 919 | 131 | $11K |
| Quetiapine Fumarate Generic | 722 | 745 | 114 | $14K |
| Divalproex Sodium Generic | 710 | 751 | 122 | $41K |
| Lisinopril Generic | 703 | 848 | 134 | $6,259 |
Brand drugs: 6,903 claims; generic drugs: 39,123 claims; opioid claims: 592.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marcel S Filart $882 ($882 in general payments such as food, travel and fees) from 9 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $415.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 17 | $415 |
| Amgen Inc. AMGN | 7 | $190 |
| Lilly USA, LLC LLY | 2 | $155 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $24.68 |
| Alkermes, Inc. ALKS | 1 | $22.81 |
| Abbott Laboratories ABT | 1 | $22.54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.19 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $16.74 |
| Gilead Sciences, Inc. GILD | 1 | $14.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.